Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Mirtti

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Theranostics|January 29, 2026
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCCTeijo Pellinen, Lassi Luomala, Kalle E Mattila, et al.
Human Gene Therapy|October 14, 2020
Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient SamplesSadia Zafar, Saru Basnet, Inga-Maria Launonen, et al.
BJU International|February 11, 2012
Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcomePolat Turker, Peter J Bostrom, Marcelo L Wroclawski, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 10, 2020
Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation studyRonja Hietikko, Tuomas P Kilpeläinen, Anu Kenttämies, et al.
Molecular Cancer Therapeutics|January 2, 2015
Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate CancerDavid T Hoang, Lei Gu, Zhiyong Liao, et al.
Cancers|January 21, 2022
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer ProgressionLan Yu, Mervi Toriseva, Syeda Afshan, et al.
European Urology|May 11, 2016
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate CancerKhalid Saeed, Vesa Rahkama, Samuli Eldfors, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 16, 2018
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activityZydrune Polianskyte-Prause, Tuomas A Tolvanen, Sonja Lindfors, et al.
BJU International|December 27, 2021
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot studyAntti Rannikko, Mare Leht, Tuomas Mirtti, et al.
Journal of the American Society of Nephrology : JASN|January 28, 2025
Integrin Trafficking, Fibronectin Architecture, and Glomerular Injury upon Adiponectin Receptor 1 DepletionSonja Lindfors, Constanze Schmotz, Dominik Lewandowski, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Theranostics|January 29, 2026
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCCTeijo Pellinen, Lassi Luomala, Kalle E Mattila, et al.
Human Gene Therapy|October 14, 2020
Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient SamplesSadia Zafar, Saru Basnet, Inga-Maria Launonen, et al.
BJU International|February 11, 2012
Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcomePolat Turker, Peter J Bostrom, Marcelo L Wroclawski, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 10, 2020
Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation studyRonja Hietikko, Tuomas P Kilpeläinen, Anu Kenttämies, et al.
Molecular Cancer Therapeutics|January 2, 2015
Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate CancerDavid T Hoang, Lei Gu, Zhiyong Liao, et al.
Cancers|January 21, 2022
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer ProgressionLan Yu, Mervi Toriseva, Syeda Afshan, et al.
European Urology|May 11, 2016
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate CancerKhalid Saeed, Vesa Rahkama, Samuli Eldfors, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 16, 2018
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activityZydrune Polianskyte-Prause, Tuomas A Tolvanen, Sonja Lindfors, et al.
BJU International|December 27, 2021
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot studyAntti Rannikko, Mare Leht, Tuomas Mirtti, et al.
Journal of the American Society of Nephrology : JASN|January 28, 2025
Integrin Trafficking, Fibronectin Architecture, and Glomerular Injury upon Adiponectin Receptor 1 DepletionSonja Lindfors, Constanze Schmotz, Dominik Lewandowski, et al.
Pageof 13